Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats

BACKGROUND: GH and IGFs serum levels decline with age. Age-related changes appear to be associated to decreases in these anabolic hormones. We have previously demonstrated that IGF-I replacement therapy improves insulin resistance, lipid metabolism and reduces oxidative damage (in brain and liver) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Castilla-Cortázar, Inma, García-Fernández, María, Delgado, Gloria, Puche, Juan E, Sierra, Inma, Barhoum, Rima, González-Barón, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150260/
https://www.ncbi.nlm.nih.gov/pubmed/21733157
http://dx.doi.org/10.1186/1479-5876-9-103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150260/
https://www.ncbi.nlm.nih.gov/pubmed/21733157
http://dx.doi.org/10.1186/1479-5876-9-103

Ejemplares similares